Characterization of Chronic Gastritis in Lynch Syndrome Patients With Gastric Adenocarcinoma.
Atrophy
Chronic gastritis
Gastric adenocarcinoma
H. pylori
Intestinal metaplasia
Lynch syndrome
MLH1
Journal
Gastroenterology research
ISSN: 1918-2805
Titre abrégé: Gastroenterology Res
Pays: Canada
ID NLM: 101519422
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
29
12
2020
accepted:
15
01
2021
entrez:
19
3
2021
pubmed:
20
3
2021
medline:
20
3
2021
Statut:
ppublish
Résumé
Gastric cancer is one of the Lynch syndrome (LS)-associated malignancies. Previous studies have suggested that LS patients with gastric cancer also had chronic atrophic gastritis in the background mucosa, but further histologic characterization was not attempted. This study aims to understand the histologic features of background chronic gastritis in LS patients with gastric adenocarcinoma. Eleven LS-associated gastric cancer cases were collected from five institutions. Demographics and clinical features were retrieved by review of medical charts. Pathological material was reviewed for tumor location and histologic type. In addition, non-neoplastic gastric mucosa was assessed for inflammation (chronic and active), atrophy, intestinal metaplasia (IM) in the antrum and body, as well as pyloric gland metaplasia and enterochromaffin-like (ECL) cell hyperplasia in the body. Eleven LS patients with gastric cancer (four male and seven female) with a mean age of 63 years (range: 23 - 83) were included. Ten (90.9%) had personal cancer histories; however none of the patients had family history of gastric cancer. Eight (72.7%) patients underwent gastrectomy and three had endoscopic resection. Nine (81.8%) patients had tumor in the fundus and/or body and two had tumor present in the antrum. Seven (63.6%) cases were intestinal type or mixed type carcinoma, and the remaining four were signet ring cell carcinoma. Eight (of 11, 72.7%) patients had chronic gastritis, five (45.4%) had atrophy, and four (36.3%) had intestinal metaplasia. Four of five patients with both antrum and body mucosa available for evaluation (80%), demonstrated body-predominant chronic gastritis. Four patients had germline None of LS patients with gastric cancer in our cohort had a family history of gastric cancer. Gastric adenocarcinomas in LS patients were primarily located in the fundus and/or body. Two-thirds of these tumors were of intestinal type and had a background chronic,
Sections du résumé
BACKGROUND
BACKGROUND
Gastric cancer is one of the Lynch syndrome (LS)-associated malignancies. Previous studies have suggested that LS patients with gastric cancer also had chronic atrophic gastritis in the background mucosa, but further histologic characterization was not attempted. This study aims to understand the histologic features of background chronic gastritis in LS patients with gastric adenocarcinoma.
METHODS
METHODS
Eleven LS-associated gastric cancer cases were collected from five institutions. Demographics and clinical features were retrieved by review of medical charts. Pathological material was reviewed for tumor location and histologic type. In addition, non-neoplastic gastric mucosa was assessed for inflammation (chronic and active), atrophy, intestinal metaplasia (IM) in the antrum and body, as well as pyloric gland metaplasia and enterochromaffin-like (ECL) cell hyperplasia in the body.
RESULTS
RESULTS
Eleven LS patients with gastric cancer (four male and seven female) with a mean age of 63 years (range: 23 - 83) were included. Ten (90.9%) had personal cancer histories; however none of the patients had family history of gastric cancer. Eight (72.7%) patients underwent gastrectomy and three had endoscopic resection. Nine (81.8%) patients had tumor in the fundus and/or body and two had tumor present in the antrum. Seven (63.6%) cases were intestinal type or mixed type carcinoma, and the remaining four were signet ring cell carcinoma. Eight (of 11, 72.7%) patients had chronic gastritis, five (45.4%) had atrophy, and four (36.3%) had intestinal metaplasia. Four of five patients with both antrum and body mucosa available for evaluation (80%), demonstrated body-predominant chronic gastritis. Four patients had germline
CONCLUSIONS
CONCLUSIONS
None of LS patients with gastric cancer in our cohort had a family history of gastric cancer. Gastric adenocarcinomas in LS patients were primarily located in the fundus and/or body. Two-thirds of these tumors were of intestinal type and had a background chronic,
Identifiants
pubmed: 33737995
doi: 10.14740/gr1359
pmc: PMC7935615
doi:
Types de publication
Journal Article
Langues
eng
Pagination
13-20Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Informations de copyright
Copyright 2021, Saulino et al.
Déclaration de conflit d'intérêts
None to declare.
Références
Int J Cancer. 1997 Oct 21;74(5):551-5
pubmed: 9355980
Dig Liver Dis. 2011 Mar;43 Suppl 4:S373-84
pubmed: 21459343
Int J Mol Sci. 2018 Jun 06;19(6):
pubmed: 29882764
Gut. 2007 Jul;56(7):926-33
pubmed: 17267619
Scand J Gastroenterol. 2002 May;37(5):574-7
pubmed: 12059060
Am J Surg Pathol. 2014 Jun;38(6):784-92
pubmed: 24518125
JAMA. 2005 Nov 2;294(17):2195-202
pubmed: 16264161
Cell Mol Gastroenterol Hepatol. 2017 Feb 28;3(2):192-200
pubmed: 28275686
Aliment Pharmacol Ther. 1998 Feb;12 Suppl 1:61-71
pubmed: 9701004
Cancer. 1987 Jul 1;60(1):51-8
pubmed: 3581033
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:31-4
pubmed: 21199511
Am J Med Genet A. 2008 May 15;146A(10):1314-9
pubmed: 18409202
Am J Surg Pathol. 1996 Oct;20(10):1161-81
pubmed: 8827022
Anticancer Res. 1997 Jul-Aug;17(4A):2647-9
pubmed: 9252695
Gastroenterology. 2010 Feb;138(2):487-92
pubmed: 19900449
J Med Genet. 2019 Dec;56(12):844-845
pubmed: 31055502
Turk J Gastroenterol. 2017 Nov;28(6):434-438
pubmed: 29086710
J Korean Med Sci. 2019 Sep 09;34(35):e231
pubmed: 31496141